Jun 29, 2026
15 MIN READ

Your Guide to Starting Wegovy: What Dose Do You Start With?

Starting semaglutide requires a carefully structured dose escalation plan designed to minimize side effects while building metabolic response. PlexusDx guides you through each phase of titration with personalized support.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 29, 2026
15 MIN READ

your guide to starting wegovy: what dose do you start with? — PlexusDx GLP-1 education

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide therapy begins with a low starting dose and gradually increases over weeks to reach your therapeutic level. This gradual titration approach—called dose escalation—helps your body adapt while reducing nausea and gastrointestinal side effects that can occur with rapid dosing increases. Understanding this process sets realistic expectations for your weight loss journey.

Understanding Semaglutide Dose Escalation Protocol

Semaglutide injections start at 0.25 mg once weekly, the lowest available dose designed to activate GLP-1 receptors without overwhelming your system. This initial phase typically lasts four weeks, allowing your digestive tract and appetite-control centers to acclimate to the medication. Most people experience mild appetite suppression at this stage, though weight loss is typically modest during the first month.

Week five introduces a step-up to 0.5 mg weekly, which roughly doubles the active compound while remaining well below doses used in diabetes management. This second phase continues for another four weeks, and many patients report noticeable appetite reduction and early weight loss momentum during this window. The body's tolerance window expands, making higher doses tolerable as your GLP-1 receptor sensitivity improves.

The third phase moves you to 1.0 mg weekly—considered the standard maintenance dose for weight loss by most prescribers. This dose level produces meaningful appetite suppression and metabolic changes in the majority of users. Some patients remain at 1.0 mg as their optimal dose, while others continue titration upward based on individual response and tolerance.

Why Slow Titration Reduces Side Effects and Improves Outcomes

Jumping directly to higher semaglutide doses triggers intense nausea, vomiting, and constipation in up to 70% of patients—side effects severe enough to cause treatment discontinuation. The gradual four-week intervals between dose increases allow your gastrointestinal tract to upregulate GLP-1 receptors progressively, shifting side-effect profiles from severe to manageable. Clinical data shows that patients following structured titration schedules report 40% fewer side-effect-related dropouts compared to accelerated protocols.

Your body's metabolic response actually strengthens with slower titration because sustained low-dose exposure builds durable appetite suppression and glucose control. Rapid escalation can paradoxically lead to faster tolerance development, meaning your body adapts and the medication becomes less effective over time. PlexusDx's titration framework respects your individual tolerance window while maximizing therapeutic benefit.

Dose Maintenance, Plateaus, and When to Adjust

Most patients reach their optimal dose between 1.0 and 2.4 mg weekly, though individual variation is substantial based on body composition, genetic metabolism, and appetite-regulation pathway sensitivity. Once you find your sweet spot—where appetite suppression is strong but side effects remain tolerable—dose adjustments become less frequent. Some people plateau in weight loss not because semaglutide stops working, but because they've reached a new metabolic set point where eating less feels sustainable without additional medication increases.

If weight loss stalls after 8–12 weeks at a stable dose, your prescriber may recommend a dose increase to 1.5 mg or 2.0 mg to re-engage appetite suppression. However, dose increases are not automatic or flat per-compound pricing escalations—PlexusDx charges a flat monthly rate regardless of dose level, so your price won't increase as your dose adjusts upward. This structure removes financial barriers to accessing the dose your body actually needs.

Personalized Dosing Through Genetic Peptide Insights

Individual semaglutide response varies significantly based on genetic variants affecting your GLP-1 receptor sensitivity, appetite-regulation pathway, and metabolic set point. The GLP1R rs6923761 variant, for example, influences how efficiently your cells bind and respond to semaglutide's active compound, meaning some people achieve full appetite suppression at 1.0 mg while others need 2.0+ mg to reach comparable results. The Precision Peptide Genetic Test from PlexusDx maps 49 peptide pathways across 14 metabolic systems, identifying which appetite and metabolic mechanisms are most responsive to semaglutide in your unique biology.

Variants in the FTO gene (rs9939609) and MC4R gene (rs17782313) also shape how aggressively your body resists weight loss and how much semaglutide you'll need to overcome biological hunger signals. Patients with genetic predispositions toward higher appetite set points often benefit from higher semaglutide doses or combination therapies earlier in treatment. PlexusDx adds the Precision Peptide Genetic Test ($99 after your first month of treatment) to guide dose decisions based on your actual genetic response profile, not just standard protocols.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the absolute starting dose of semaglutide for weight loss?

Semaglutide weight-loss therapy begins at 0.25 mg injected once weekly for the first four weeks. This lowest available dose activates your GLP-1 receptors gently while your body acclimates to the medication. PlexusDx coordinates this initial phase with your clinician to ensure smooth tolerance and early symptom management.

How long does each dose level stay the same before increasing?

Each dose level is typically maintained for four weeks before stepping up to the next tier. This four-week interval allows your gastrointestinal system and metabolic pathways to adapt fully. Clinical evidence shows this schedule minimizes severe side effects while maintaining steady weight-loss momentum.

Does my PlexusDx price increase when my dose increases?

No. PlexusDx charges a flat monthly rate for compounded semaglutide injections starting at $149/mo, and your dose may need to go up while your price won't. Whether you're at 0.25 mg or 2.4 mg weekly, you pay the same rate, removing financial barriers to accessing your optimal therapeutic dose.

Can I skip dose increases or stay at a lower dose permanently?

Absolutely. If you achieve your weight-loss goals or find that a lower dose balances appetite suppression with side-effect tolerability, you can remain at that dose indefinitely. Semaglutide is not a race to the highest dose—it's finding the dose that works best for your body and goals.

How does the Precision Peptide Genetic Test predict my ideal semaglutide dose?

The Precision Peptide Genetic Test examines variants like GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 that directly influence your appetite-regulation sensitivity and metabolic resistance. These insights help PlexusDx clinicians predict whether you'll respond robustly to standard doses or may need higher or combination therapies. This genetic roadmap personalizes your entire titration schedule.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves